MiNK Therapeutics, Inc. (INKT) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of MiNK Therapeutics, Inc. and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INKT
MiNK Therapeutics, Inc.
$12.06HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
ONCY
Oncolytics Biotech Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 12:19 PM EDT
Total return — INKT vs ONCY
growth of $100 · dividends reinvested · last 5yINKT -89.8% (-36.7%/yr)ONCY -71.8% (-22.4%/yr)ONCY compounded faster over this window
INKT ONCY
INKT vs ONCY: by the numbers
- •INKT is the larger company ($60M vs $60M market cap).
Metrics side by side
Profitability
| Metric | INKT | ONCY |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROIC | -604.20% | -1235.48% |
Growth (annualized)
| Metric | INKT | ONCY |
|---|---|---|
| Total return CAGR (5Y) | N/A | -21.00% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.